CDSCO Panel rejects Zydus Healthcare's proposal to waive Phase III CT of Diphenhydramine, Phenylephrine FDC Dr. Divya Colin30 Dec 2024 5:45 PM ISTNew Delhi: Denying the proposal for a phase III clinical trial (CT) waiver, the Subject Expert Committee (SEC) functional under the Central Drug...
Conduct Phase III CT: CDSCO Panel Tells Zydus Healthcare on FDC Dextromethorphan, Phenylephrine Syrup Dr. Divya Colin20 Dec 2024 6:00 PM ISTNew Delhi: Reviewing the justification for the Phase III clinical trial of Zydus Healthcare's fixed dose combination (FDC) pulmonary drug...
Conduct Phase III CT: CDSCO Panel Tells Zydus Healthcare on Glycopyrrolatem plus Indacaterol metered dose inhalation Dr. Divya Colin24 Nov 2024 5:30 PM ISTNew Delhi: Considering the bioequivalence study report presented by Zydus Healthcare, the Subject Expert Committee (SEC) functional under the Central...
Delhi HC Grants Relief to Zydus in BIOCHEM Trademark Dispute Farhat Nasim18 Nov 2024 3:28 PM ISTNew Delhi: In relief to Zydus Healthcare, the Delhi High Court has granted an injunction restraining Alder Biochem Pvt. Ltd. from using the trademark...
Submit active controlled CT design for moderate to very severe COPD patients: CDSCO Panel tells Zydus Healthcare on Revefenacin inhalation Dr. Divya Colin16 Nov 2024 6:00 PM ISTNew Delhi: Responding to Zydus Healthcare's proposal to manufacture and market Revefenacin Inhalation Solution 175 mcg/3ml, the Subject Expert...
Zydus Healthcare gets Rs 284.58 crore income tax demand notice Roshni Dhar28 Dec 2023 5:51 PM ISTZydus Lifesciences on Tuesday said its arm Zydus Healthcare Ltd has been served an income tax notice demand of Rs 284.58 crore for the assessment year...
Health Bulletin 28/December/2023 Roshni Dhar28 Dec 2023 4:16 PM ISTHere are the top health stories for the day:Delhi: CISF seizes medicines worth Rs 80 lakh at IGI airport, two heldTwo international passengers were...
Zydus Healthcare gets Rs 284.58 crore income tax demand notice Ruchika Sharma27 Dec 2023 3:29 PM ISTThe demand is determined due to "apparent mistakes while processing its return of income', it said.
Conduct bioequivalence study: CDSCO Panel tells Zydus Healthcare on Glycopyrrolate, Indacaterol Metered dose inhalation Dr. Divya Colin22 Dec 2023 6:00 PM ISTNew Delhi: Rejecting the clinical trial waiver proposal, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Zydus Healthcare Gets CDSCO panel Nod To Market Vilanterol, Glycopyrrolate FDC metered dose inhalation Dr. Divya Colin23 Nov 2023 6:00 PM ISTNew Delhi: The drug major Zydus Healthcare has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
Conduct Phase III clinical trial: CDSCO to Zydus Healthcare over FDC Empagliflozin plus Sitagliptin Dr. Divya Colin12 Nov 2023 4:00 PM ISTNew Delhi: In response to the proposal presented by the drug major Zydus Healthcare, the Subject Expert Committee ( SEC) functional under the Central...
Zydus Healthcare gets CDSCO Panel nod to study Fluticasone Furoate, Glycopyrronium, Vilanterol FDC Dr. Divya Colin22 Oct 2023 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO) has approved drug major Zydus...
